Anika Therapeutics Inc
NASDAQ:ANIK

Watchlist Manager
Anika Therapeutics Inc Logo
Anika Therapeutics Inc
NASDAQ:ANIK
Watchlist
Price: 16.31 USD -0.12%
Market Cap: 238.9m USD
Have any thoughts about
Anika Therapeutics Inc?
Write Note

Anika Therapeutics Inc
Tax Provision

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Anika Therapeutics Inc
Tax Provision Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Tax Provision CAGR 3Y CAGR 5Y CAGR 10Y
Anika Therapeutics Inc
NASDAQ:ANIK
Tax Provision
-$3m
CAGR 3-Years
N/A
CAGR 5-Years
22%
CAGR 10-Years
18%
Abbvie Inc
NYSE:ABBV
Tax Provision
-$2.1B
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-6%
Gilead Sciences Inc
NASDAQ:GILD
Tax Provision
-$63m
CAGR 3-Years
68%
CAGR 5-Years
48%
CAGR 10-Years
30%
Amgen Inc
NASDAQ:AMGN
Tax Provision
-$449m
CAGR 3-Years
19%
CAGR 5-Years
19%
CAGR 10-Years
0%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Tax Provision
-$739.4m
CAGR 3-Years
-9%
CAGR 5-Years
-31%
CAGR 10-Years
-61%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Tax Provision
-$314.9m
CAGR 3-Years
33%
CAGR 5-Years
-20%
CAGR 10-Years
3%
No Stocks Found

Anika Therapeutics Inc
Glance View

Market Cap
239.7m USD
Industry
Biotechnology

Anika Therapeutics, Inc. is an orthopedic and regenerative medicines company, which develops, manufactures and commercializes therapeutic products for pain management, tissue regeneration, and wound healing. The company is headquartered in Bedford, Massachusetts and currently employs 297 full-time employees. The firm is focused on developing, manufacturing, and commercializing products based on its hyaluronic acid (HA) technology platform. The Company’s product include OA Pain Management product consists of Monovisc and Orthovisc, which is single and multi-injection, HA-based viscosupplement product, Cingal, and Hyvisc; Joint Preservation and Restoration product consists of bone preserving joint technologies, soft tissue repair and regenerative solutions, and Non-Orthopedic product consists of Hyalobarrier, an anti-adhesion barrier indicated for use after abdomino-pelvic surgeries. Hyalomatrix is used for the treatment of wounds, such as burns, ulcers, ears, nose and throat disorders, and ophthalmic products.

ANIK Intrinsic Value
12.08 USD
Overvaluation 26%
Intrinsic Value
Price

See Also

What is Anika Therapeutics Inc's Tax Provision?
Tax Provision
-3m USD

Based on the financial report for Sep 30, 2024, Anika Therapeutics Inc's Tax Provision amounts to -3m USD.

What is Anika Therapeutics Inc's Tax Provision growth rate?
Tax Provision CAGR 10Y
18%

Back to Top